Two U.S. healthcare technology companies have announced a significant transaction that could shake up the country’s electrophysiology market. 

Merit Medical Systems, a Utah-based medical device…

Biotronik has received U.S. Food and Drug Administration (FDA) approval to make its Solia S lead and Selectra 3D catheter available for a new indication: left bundle branch area pacing (LBBAP). 

LBBAP…

Performing low-voltage-area (LVA) ablation after pulmonary vein isolation (PVI) when treating persistent atrial fibrillation (AFib) does not appear to improve outcomes, according to a new analysis presented at…

The first modular, leadless cardiac rhythm management (CRM) system composed of a leadless pacemaker and a subcutaneous, leadless implantable cardioverter defibrillator (ICD) was linked to positive early results at…

PaceMate, a Florida-based company focused on remote monitoring and patient management technologies, has acquired Medtronic’s…

The U.S. Food and Drug Administration (FDA) has announced that Defibtech, a Nihon Kohden company, is recalling its RMU-2000 ARM XR Chest Compression Device due to significant safety concerns. This is…

Left atrial appendage occlusion (LAAO) with the Watchman FLX device from Boston Scientific is associated with positive outcomes and limited adverse events after one year, according to new findings published in Circulation:…

Huxley Medical, an Atlanta-based medical device company, has secured U.S. Food and Drug Administration (FDA) clearance for its new Sansa device, a chest-worn…

Treating mitral regurgitation with transcatheter mitral edge-to-edge repair (TEER) using the MitraClip device is associated with a…

How can cardiologists limit ischemic strokes in patients with atrial fibrillation (AFib) following a successful transcatheter aortic valve…

Asking pharmacists to play a more active role in patient care can help patients with undiagnosed and undertreated atrial fibrillation (AFib) receive the care they need, according to a new study published in JAMA Network…

FibriCheck, a Belgium-based healthcare technology company, has gained U.S. Food and Drug Administration (FDA) for its …

Volta Medical, a French healthcare company focused on improving care for atrial fibrillation (AFib) patients, has agreed to integrate its artificial…

When patients require a permanent pacemaker (PPM) after transcatheter aortic valve replacement (TAVR), should care teams turn to a…

Cardiology salaries have continued to climb in 2024, according to a new survey from the American Medical Group Association (AMGA). Among general cardiologists, for example, median compensation…

Pulse Biosciences, a Florida-based healthcare technology company, has received the FDA’s breakthrough device designation for its new CellFX Nanosecond Pulsed Field Ablation (PFA) technology.

…

Pulsed field ablation (PFA) has gained significant momentum as a treatment option for atrial fibrillation (AFib) in recent months, with both…

Medicare Part B enrollees will pay significantly less for 64 different prescription medications for the next three months, according to a new announcement from the U.S. Department of Health and Human…

Chicago-based Tempus AI has gained clearance from the U.S. Food and Drug Administration (FDA) for a new artificial intelligence…